doi: 10.1056/NEJMoa2206038 Wegovy (semaglutide) prescribing information
Photos may be taken for comparison later
Under IRS rules, weight-loss treatment can qualify as an HSA- or FSA-eligible medical expense when it is prescribed for a specific diagnosed condition obesity, type 2 diabetes, hypertension, dyslipidemia, or cardiovascular disease rather than for general wellness or cosmetic weight loss
Schloot, et al., 'Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial', Lancet Diabetes Endocrinol
Glycine acts as an inhibitory neurotransmitter that lowers core body temperature at bedtime a critical signal for sleep onset [41]
Any perceived difference in speed is likely psychological rather than physiological